高发酵食品对局部晚期直肠癌患者的干预(FEED 试验)
对局部晚期直肠癌患者进行随机高发酵食物干预(FEED 试验)
The purpose of the study is to evaluate the feasibility and acceptability of a dietary intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal cancer patients and non-small cell lung cancer (NSCLC) patients, and to explore whether this diet can improve outcomes in rectal cancer patients receiving chemoradiation and NSCLC patients receiving immunotherapy.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Florida
-
Tampa、Florida、美国、33612
- Moffitt Cancer Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria for GI Patients:
- 18 years of age or older
- Diagnosed with locally advanced rectal cancer (Stage II-III)
- Will undergo neoadjuvant chemoradiation at Moffitt Cancer Center
- Able to pick up FFs once/weekly at Moffitt
- Able to speak and read English
- Able to consume foods orally
- Able to provide informed consent
Inclusion Criteria for Thoracic Patients:
- 18 years of age or older
- Diagnosed with stage II-IV non-small cell lung cancer (NSCLC)
- Will undergo Immunotherapy with immune checkpoint inhibitors (+/- chemotherapy or other treatment) at Moffitt Cancer Center
- Able to pick up FFs once/weekly at Moffitt
- Able to speak and read English
- Able to consume foods orally
- Able to provide informed consent
Exclusion Criteria:
- Antibiotic use within 1 month prior to baseline
- If currently using probiotics, unwillingness to cease probiotic use
- Previous receipt of surgery, immunotherapy, chemotherapy, or radiation for a colon or rectal tumor
- Per clinician's discretion, clinician confirmed inflammatory bowel conditions (e.g., ulcerative colitis, Crohn's disease)
- Infectious disease diagnosed <1 month prior to baseline
- Already consuming ≥2 servings of fermented foods/day
- Previously diagnosed with a mast cell disorder or histamine allergy
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:FEED-FF
Participants will be asked to pick up the fermented foods at the Research Kitchen at Moffitt. Participants will be asked to eat 3-6 servings of FFs per day, from 1 week prior to treatment start through 12 weeks after treatment start/until the restaging scope is completed. At baseline, the end of week 6.5 and again at week 12.5, participants will be asked to provide biospecimens including a stool sample collected at home and a blood specimen collected in clinic. Participants will be asked to complete a food frequency questionnaire, a quality-of-life survey, two symptom related surveys, and a stool collection questionnaire at these same timepoints. After the dietary intervention, participants will be asked to complete an exit survey to provide feedback on the study and intervention. |
3-6 servings of any combination of the following fermented foods/day (from 1 week prior to treatment to approximately 12 weeks after the start of treatment): Yogurt, cottage cheese, kefir, kombucha, sauerkraut, and kimchi. |
|
有源比较器:Standard of Care (SUC)
Participants will receive general healthy eating handouts similar to current usual care documents provided in clinic. These handouts will detail typical healthy foods and the suggested level of intake, or servings per day. At baseline, the end of week 6.5 and again at week 12.5, participants will be asked to provide biospecimens including a stool sample collected at home and a blood specimen collected in clinic. Participants will be asked to complete a food frequency questionnaire, a quality-of-life survey, two symptom related surveys, and a stool collection questionnaire at these same timepoints. |
Standard of Care (SUC) is the treatment that is accepted by medical experts as a proper treatment for a certain type of disease and that is widely used by health care professionals. Standard of Care will comprise general healthy eating handouts that describe typical healthy foods and the suggested level of servings per day. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Effects of the FEED-FF diet on clinical response to chemoradiation (Rectal Cancer Patients)
大体时间:At Baseline and Up to 12.5 Weeks
|
Clinical response measured in clinic by MRI/Endoscopy/Digital rectal exam, comparing the FEED-FF arm to SUC arm. Indicators of clinical response are Complete Response, Near Complete Response, Incomplete Response, or Progressive Disease. |
At Baseline and Up to 12.5 Weeks
|
|
Effects of the FEED-FF diet on clinical response to immunotherapy (Lung Cancer Patients)
大体时间:At Baseline and Up to 12.5 Weeks
|
Clinical benefit to immune checkpoint inhibitor therapy will be measured in clinic by MRI/Endoscopy, comparing the FEED-FF arm to SUC arm. Defined as the best response of complete tumor resolution (CR), Partial Response (PR), and stable tumor size (SD) within 12 months. Progressive Disease (PD) within 12 months indicates no clinical benefit. |
At Baseline and Up to 12.5 Weeks
|
|
Effects of FEED-FF diet on the gut microbiome
大体时间:At Baseline, Week 6.5 and Up to 12.5 Weeks
|
Measured by fecal biospecimen sample collection; FEED-FF arm hypothesized to demonstrate increases in short chain fatty acid (SCFA) producing bacteria and higher alpha diversity compared to SUC arm. |
At Baseline, Week 6.5 and Up to 12.5 Weeks
|
|
Effects of FEED-FF diet on local immune-related biomarkers
大体时间:At Baseline and Up to 12.5 Weeks
|
Measured by FFPE tissue slides; FEED-FF arm hypothesized to demonstrate enhanced immune response such as higher T-cell expression compared to SUC arm. |
At Baseline and Up to 12.5 Weeks
|
|
Effects of FEED-FF diet on quality of life
大体时间:At Baseline, Week 6.5 and Up to 12.5 Weeks
|
Measured by using the European Organization for the Research and Treatment of Cancer (EORTC) Quality of Life (QoL) Survey; FEED-FF arm hypothesized to demonstrate more favorable QoL compared to SUC arm. |
At Baseline, Week 6.5 and Up to 12.5 Weeks
|
|
Efficacy of the FEED-FF intervention
大体时间:At Baseline, Week 6.5 and Up to 12.5 Weeks
|
Measured by an accrual rate of 50% of eligible patients, fermented foods (FF) intake of at least 3 servings on at least 80% of days, and at least 80% of intervention group reporting high/very high satisfaction with intervention. Weekly goal adherence via randomly administered food logs, tracking responses to and general completion of an exit survey will be utilized. |
At Baseline, Week 6.5 and Up to 12.5 Weeks
|
|
Feasibility of the FEED-FF intervention
大体时间:At Baseline, Week 6.5 and Up to 12.5 Weeks
|
Measured by an accrual rate of 50% of eligible patients, fermented foods (FF) intake of at least 3 servings on at least 80% of days, and at least 80% of intervention group reporting high/very high satisfaction with intervention. Weekly goal adherence via randomly administered food logs, tracking responses to and general completion of an exit survey will be utilized. |
At Baseline, Week 6.5 and Up to 12.5 Weeks
|
合作者和调查者
调查人员
- 首席研究员:Doratha (Armen) Byrd, PhD, MPH、Moffitt Cancer Center
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.